UA92324C2 - Novel 2-substituted d-homo-estra-1,3,5(10)-trienes as inhibitors of 17я-hydroxysteroid dehydrogenase type 1 - Google Patents

Novel 2-substituted d-homo-estra-1,3,5(10)-trienes as inhibitors of 17я-hydroxysteroid dehydrogenase type 1

Info

Publication number
UA92324C2
UA92324C2 UAA200701040A UAA200701040A UA92324C2 UA 92324 C2 UA92324 C2 UA 92324C2 UA A200701040 A UAA200701040 A UA A200701040A UA A200701040 A UAA200701040 A UA A200701040A UA 92324 C2 UA92324 C2 UA 92324C2
Authority
UA
Ukraine
Prior art keywords
trienes
estra
homo
substituted
novel
Prior art date
Application number
UAA200701040A
Other languages
English (en)
Inventor
Кристиан Геге
Вилко Регенхардт
Олаф Петерс
Александер Хиллиш
Йерци Адамски
Габриэле Мёллер
Доминга Делука
Вальтер Эльгер
Биргитт Шнайдер
Original Assignee
Байер Шеринг Фарма Акциенгезелльшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байер Шеринг Фарма Акциенгезелльшафт filed Critical Байер Шеринг Фарма Акциенгезелльшафт
Publication of UA92324C2 publication Critical patent/UA92324C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
UAA200701040A 2004-07-02 2005-04-07 Novel 2-substituted d-homo-estra-1,3,5(10)-trienes as inhibitors of 17я-hydroxysteroid dehydrogenase type 1 UA92324C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004032673A DE102004032673A1 (de) 2004-07-02 2004-07-02 Neue 2-substituierte D-Homo-estra-1,3,5(10)-triene als Inhibitoren der 17ß-Hydroxysteroiddehydrogenase Typ 1

Publications (1)

Publication Number Publication Date
UA92324C2 true UA92324C2 (en) 2010-10-25

Family

ID=35106828

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200701040A UA92324C2 (en) 2004-07-02 2005-04-07 Novel 2-substituted d-homo-estra-1,3,5(10)-trienes as inhibitors of 17я-hydroxysteroid dehydrogenase type 1

Country Status (25)

Country Link
EP (1) EP1763534B1 (ru)
JP (1) JP4871274B2 (ru)
KR (1) KR20070035059A (ru)
CN (1) CN1980949B (ru)
AT (1) ATE458744T1 (ru)
AU (1) AU2005259329B8 (ru)
BR (1) BRPI0511394A (ru)
CA (1) CA2571760C (ru)
CR (1) CR8854A (ru)
DE (2) DE102004032673A1 (ru)
DK (1) DK1763534T3 (ru)
EA (1) EA011455B1 (ru)
EC (1) ECSP077160A (ru)
ES (1) ES2340401T3 (ru)
HK (1) HK1103745A1 (ru)
HR (1) HRP20100230T1 (ru)
IL (1) IL180171A0 (ru)
MX (1) MX2007000108A (ru)
NO (1) NO20070605L (ru)
NZ (1) NZ552515A (ru)
PL (1) PL1763534T3 (ru)
PT (1) PT1763534E (ru)
UA (1) UA92324C2 (ru)
WO (1) WO2006003012A1 (ru)
ZA (1) ZA200700958B (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8030298B2 (en) 2005-05-26 2011-10-04 Abbott Products Gmbh 17β-HSD1 and STS inhibitors
US8080540B2 (en) 2006-09-19 2011-12-20 Abbott Products Gmbh Therapeutically active triazoles and their use
US8288367B2 (en) 2006-11-30 2012-10-16 Solvay Pharmaceuticals Gmbh Substituted estratriene derivatives as 17BETA HSD inhibitors
DE102007015169A1 (de) 2007-03-27 2008-10-02 Universität des Saarlandes Campus Saarbrücken 17Beta-Hydroxysteroid-Dehydrogenase-Typ1-Inhibitoren zur Behandlung hormonabhängiger Erkrankungen
DE102007040243A1 (de) 2007-08-25 2009-02-26 Universität des Saarlandes 17Beta-Hydroxysteriod-Dehydrogenase Typ1 Inhibitoren zur Behandlung hormonabhängiger Erkrankungen
US9850272B2 (en) 2013-06-25 2017-12-26 Forendo Pharma Ltd. Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-hydroxy-steroid dehydrogenase, type 1
US10377791B2 (en) 2013-06-25 2019-08-13 Forendo Pharma Ltd. Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydroxysteroid dehydrogenase, type 1
US9663549B2 (en) 2013-06-25 2017-05-30 Forendo Pharma Ltd. Therapeutically active 17-nitrogen substituted estratreinthiazole derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase
CN107207562B (zh) 2014-12-23 2020-03-06 佛恩多制药有限公司 17β-HSD1抑制剂的前药
CN107207561B (zh) 2014-12-23 2020-03-31 佛恩多制药有限公司 17β-HSD1–抑制剂的前药
CZ307437B6 (cs) 2016-06-07 2018-08-22 Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v.v.i. 15β-substituované deriváty estronu jako selektivní inhibitory 17β-hydroxysteoiddehydrogenáz
UA126342C2 (uk) 2017-06-08 2022-09-21 Форендо Фарма Лтд 15-бета-[3-пропанамідо]-заміщені естра-1,3,5(10)-трієн-17-он-сполуки і їх 17-оксими для використання в інгібуванні 17-бета-гідроксистероїддегідрогеназ
SG11202105795XA (en) 2018-12-05 2021-06-29 Forendo Pharma Ltd Estra-1,3,5(10)-triene compounds condensed in position 16(17) with a pyrazole ring as inhibitors of 17-hsd1

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3005835A (en) * 1960-09-13 1961-10-24 Searle & Co D-homo-18-norestra-1, 3, 5(10)-trien-17alpha-ones and intermediates thereto
GB1346691A (en) * 1970-06-12 1974-02-13 Inst Khim Prirodnykh Soedineny Stereospecific method for preparing estrane compounds of natural configuration
JPH06279488A (ja) * 1993-03-29 1994-10-04 Kuraray Co Ltd 新規なステロイド誘導体および骨粗鬆症治療剤
PL343862A1 (en) * 1998-03-11 2001-09-10 Endorech Inhibitors of type 5 and type 3 17β−hydroxysteroid dehydrogenase and methods for their use
DE10151365A1 (de) * 2001-10-17 2003-04-30 Schering Ag 17-Chlor-D-Homosteroide als selektive Estrogenrezeptorantagonisten
WO2003017974A1 (en) * 2001-08-31 2003-03-06 Pantarhei Bioscience B.V. Method of treating benign gynaecological disorders and a pharmaceutical kit for use in such method
DE10307103A1 (de) * 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte D-Homostra-1,3,5(10)-trien-3-yl sulfamate
DE102004032674A1 (de) * 2004-07-02 2006-01-26 Schering Ag Neue 2-substituierte Estra-1,3,5(10)-trien-17-one als Inhibitoren der 17β-Hydroxysteroiddehydrogenase Typ 1

Also Published As

Publication number Publication date
ES2340401T3 (es) 2010-06-02
CA2571760A1 (en) 2006-01-12
AU2005259329B8 (en) 2011-11-24
AU2005259329A1 (en) 2006-01-12
MX2007000108A (es) 2007-03-09
DK1763534T3 (da) 2010-05-17
CN1980949B (zh) 2010-05-05
PT1763534E (pt) 2010-04-27
EP1763534B1 (de) 2010-02-24
ZA200700958B (en) 2008-07-30
CN1980949A (zh) 2007-06-13
EP1763534A1 (de) 2007-03-21
WO2006003012A1 (de) 2006-01-12
KR20070035059A (ko) 2007-03-29
PL1763534T3 (pl) 2010-07-30
CR8854A (es) 2007-08-28
HRP20100230T1 (hr) 2010-06-30
ATE458744T1 (de) 2010-03-15
DE102004032673A1 (de) 2006-01-26
JP2008504337A (ja) 2008-02-14
JP4871274B2 (ja) 2012-02-08
IL180171A0 (en) 2007-06-03
EA200700103A1 (ru) 2007-08-31
CA2571760C (en) 2011-11-22
EA011455B1 (ru) 2009-04-28
NO20070605L (no) 2007-02-01
NZ552515A (en) 2010-07-30
HK1103745A1 (en) 2007-12-28
DE502005009091D1 (de) 2010-04-08
BRPI0511394A (pt) 2007-12-04
AU2005259329B2 (en) 2011-11-10
ECSP077160A (es) 2007-02-28

Similar Documents

Publication Publication Date Title
UA92324C2 (en) Novel 2-substituted d-homo-estra-1,3,5(10)-trienes as inhibitors of 17я-hydroxysteroid dehydrogenase type 1
TW200833675A (en) Nicotinamide derivatives
JOP20210301A1 (ar) بيرولات ثلاثية الحلقة مكثفة كمُعدِّلات مضاد تريبسين ألفا-1
DE60315674D1 (de) Neue imidazopyridine und ihre verwendung
WO2010089303A9 (en) CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1
IL166412A0 (en) Novel use of benzothiazole derivatives
TN2010000293A1 (en) Thiazole derivatives used as pi 3 kinase inhibitors
TW200609227A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
NZ598242A (en) Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor and erythropoietin production inducer
NO20090755L (no) Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
PT1960352E (pt) Derivados de 2-adamantilureia como inibidores seletivos de 11â-hsd1
WO2009075835A8 (en) CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1
MX2009008779A (es) Composicion farmacéutica que comprende derivado de pirazina y método para usar el derivado de pirazina en combinación.
NO20052730L (no) Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser
WO2006003013A3 (de) NEUE 2-SUBSTITUIERTE ESTRA-1,3,5(10)-TRIEN-17-ONE ALS INHIBITOREN DER 17β-HYDROXYSTEROIDDEHYDROGENASE TYP 1
TW200619212A (en) Morpholine derivatives
HK1146049A1 (en) Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1
MX2009005201A (es) Derivados de estratrieno sustituidos como inhibidores de 17beta hsd.
SE0301232D0 (sv) Novel use
UA102397C2 (ru) Производные индола как активаторы nurr-1 и их применение для лечения болезни паркинсона
ATE495159T1 (de) Diaminocyclohexan- und diaminocyclopentanderivate
NO20060277L (no) Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger
MXPA05001469A (es) Uso de extracto de germen de trigo fermentado como agente anti-inflamatorio.
SE0402591D0 (sv) Novel use
WO2009019719A3 (en) Process for the preparation of 3-aryloxy-3-arylpropanamines